StockMacro
Menu

Abeona Therapeutics

$2.42 -56% in 6 monthsMarket cap $165.3M

ABEO on XNAS, Health Care, Abeona Therapeutics Inc., job postings

Measures activity, not value. Not investment advice.

Shares fell 46% in a month as short interest reached 30% and the 12-month net loss hit $62.5M.

  • BadFree cash outflow of $66.3M over 12 months against $134.9M cash
  • WatchCapital spending fell 91% to $219K in quarter ended 30 Sep

Written by AI from the data on this page, 22 Nov 2026. Not investment advice.

Profile and fundamentals

From its SEC filings, 12 months to 30 Sep 2026

Abeona Therapeutics Inc is a commercial-stage biopharmaceutical company. The company is focused on developing cell and gene therapies for life-threatening diseases. The company's ZEVASKYN (prademagene zamikeracel) is an autologous cell-based gene therapy for the treatment of wounds in adults and pediatric patients with recessive dystrophic epidermolysis bullosa (RDEB). The company's development portfolio includes adeno-associated virus (AAV)-based gene therapies for ophthalmic diseases with high unmet medical need.

Industry
Pharmaceutical preparations (Health Care)
Employees
226
Website
abeonatherapeutics.com
Listed
Nasdaq, US
Last results
9 Nov 2026
Next results
expected around 16 Mar 2027 (an estimate: a year ago it reported on 17 Mar 2026)
Revenue and net income per quarter. Quarter to 30 Sep 2026: revenue $13.5M, net loss $4.8M.
Quarter to 31 Dec 2021: revenue –, net income -$46.7MQuarter to 31 Mar 2022: revenue $346K, net income -$20.8MQuarter to 31 Mar 2022: revenue $346K, net income -$20.8MQuarter to 30 Jun 2022: revenue $1.0M, net income -$8.3MQuarter to 30 Jun 2022: revenue $1.0M, net income -$8.3MQuarter to 30 Sep 2022: revenue –, net income -$9.5MQuarter to 31 Dec 2022: revenue $68K, net income -$1.1MQuarter to 31 Dec 2022: revenue $68K, net income -$1.1MQuarter to 31 Mar 2023: revenue –, net income -$9.1MQuarter to 30 Jun 2023: revenue $3.5M, net income -$16.7MQuarter to 30 Jun 2023: revenue $3.5M, net income -$16.7MQuarter to 30 Sep 2023: revenue $0, net income -$11.8MQuarter to 30 Sep 2023: revenue $0, net income -$11.8MQuarter to 31 Dec 2023: revenue $0, net income -$16.6MQuarter to 31 Dec 2023: revenue $0, net income -$16.6MQuarter to 31 Mar 2024: revenue –, net income -$31.6MQuarter to 30 Jun 2024: revenue –, net income $7.4MQuarter to 30 Sep 2024: revenue –, net income -$30.3MQuarter to 31 Dec 2024: revenue –, net income -$9.3MQuarter to 31 Mar 2025: revenue –, net income -$12.0MQuarter to 30 Jun 2025: revenue $400K, net income $108.8MQuarter to 30 Jun 2025: revenue $400K, net income $108.8MQuarter to 30 Sep 2025: revenue –, net income -$5.2MQuarter to 31 Dec 2025: revenue $5.4M, net income -$20.5MQuarter to 31 Dec 2025: revenue $5.4M, net income -$20.5MQuarter to 31 Mar 2026: revenue $8.7M, net income -$17.1MQuarter to 31 Mar 2026: revenue $8.7M, net income -$17.1MQuarter to 30 Jun 2026: revenue $11.4M, net income -$20.2MQuarter to 30 Jun 2026: revenue $11.4M, net income -$20.2MQuarter to 30 Sep 2026: revenue $13.5M, net income -$4.8MQuarter to 30 Sep 2026: revenue $13.5M, net income -$4.8M
31 Dec 2021RevenueNet incomeNet losstallest bar $108.8M30 Sep 2026
See the numbers
Quarter toRevenueNet income
30 Sep 2026$13.5M-$4.8M
30 Jun 2026$11.4M-$20.2M
31 Mar 2026$8.7M-$17.1M
31 Dec 2025$5.4M-$20.5M
30 Sep 2025–-$5.2M
30 Jun 2025$400K$108.8M
31 Mar 2025–-$12.0M
31 Dec 2024–-$9.3M
30 Sep 2024–-$30.3M
30 Jun 2024–$7.4M
31 Mar 2024–-$31.6M
31 Dec 2023$0-$16.6M
30 Sep 2023$0-$11.8M
30 Jun 2023$3.5M-$16.7M
31 Mar 2023–-$9.1M
31 Dec 2022$68K-$1.1M
30 Sep 2022–-$9.5M
30 Jun 2022$1.0M-$8.3M
31 Mar 2022$346K-$20.8M
31 Dec 2021–-$46.7M
Fundamentals, 12 months to 30 Sep 2026
MeasureLatestYear beforePeer median
RevenueSales over the last 12 months reported. $39.0M –
Revenue growthRevenue of the last 12 months compared with the 12 months before. – +11%
Net incomeProfit after all costs and taxes over the last 12 months reported. Negative is a loss. -$62.5M $82.3M
EPS (diluted)Earnings per share: net income divided by the shares, counting options and convertibles. Left blank when the figures as filed do not fit today's share count (after a split). -$1.07 $1.23
Gross marginWhat is left of each dollar of sales after the direct cost of making the product or service. 65.1% – 73.2%
Operating marginOperating income as a share of sales: profit from the business before interest and taxes. -186% – -25.0%
Net marginNet income as a share of sales: what the owners keep of each dollar sold. -160% – -18.2%
Return on equityNet income of the last 12 months divided by shareholders' equity (the average of the latest balance sheet and the one a year earlier): the profit made on the owners' money. -42.1% -58.8%
Free cash flowCash from operations minus capital spending over the last 12 months: cash the business produced. -$66.3M -$82.4M
CashCash, cash equivalents and short-term investments on the latest balance sheet. $134.9M $207.1M
DebtShort- and long-term borrowings on the latest balance sheet. Operating leases are not counted. $11.8M $19.8M
Net debtDebt minus cash. Negative means the company holds more cash than it owes (net cash). -$123.1M (net cash) -$187.4M
Debt to equityDebt divided by shareholders' equity on the latest balance sheet: how much is borrowed for each dollar the owners have in the company. Blank when equity is negative. 0.09 0.0
Book value per shareShareholders' equity (assets minus liabilities) on the latest balance sheet divided by the shares outstanding. $2.20
P/EPrice to earnings: market cap divided by net income of the last 12 months. What investors pay for one dollar of yearly profit. Blank when the company made a loss. loss 19.3
P/SPrice to sales: market cap divided by revenue of the last 12 months. 3.5 5.0
EV/SalesEnterprise value (market cap plus debt minus cash) divided by revenue of the last 12 months. 0.39 5.0
P/BPrice to book: market cap divided by shareholders' equity on the latest balance sheet. Blank when equity is negative. 1.1 2.0

Latest = 12 months to 30 Sep 2026; balance-sheet lines at its end. Peer median: companies in the same industry (SIC code), or the sector when the industry is small.

Peers nearest by market cap, its own industry first

CompanyMarket capP/EP/SRevenue growthNet margin
Abeona TherapeuticsABEO (this company) $165.3Mloss3.5–-160%
Korro BioKRRO $167.2Mloss129-82%–
Entrada TherapeuticsTRDA $170.3Mloss42.8-94%–
SIGA TechnologiesSIGA $172.5M2513.3-70%1.3%
Oramed PharmaceuticalsORMP $155.2M––––
VogenxVOGX $176.3M––––

Insider Buy/Sell Shares the company's insiders (directors, officers and owners of 10% or more) bought minus what they sold on the open market in the last 90 days, from their Form 4 filings.

-$262K

bought $34K, sold $297K

Institutional holders The number of institutional investment managers (13F filers: funds, pensions, asset managers) reporting the stock, compared with the quarter before. 13F reports are public 45 days after quarter end and show long positions only.

-9.5%

114 13F filers vs 126

Institutional ownership Shares held by 13F filers at the latest quarter end, divided by the shares outstanding in the company's latest filing. Above 100% usually means a stale share count or double counting, and is marked.

71%

40.8M shares held by 13F filers (30 Sep 2026) of 57.1M outstanding (5 Nov 2026)

Short interest Shares sold short and not yet bought back, divided by the shares outstanding in the company's latest filing. From FINRA's latest short interest report: FINRA reports twice a month and publishes 7 business days after the settlement date. Above 100% means a stale share count, and is marked.

30%

16.9M shares sold short (30 Oct 2026) of 57.1M outstanding (5 Nov 2026)

Days to cover Short interest divided by the stock's average daily trading volume, as FINRA publishes it: how many days of normal trading it would take short sellers to buy back every share. Latest report.

21.7

16.9M shares sold short (30 Oct 2026) divided by the stock's average daily volume, as FINRA publishes it

Short interest change How the number of shares sold short changed between FINRA's two latest reports, about two weeks apart.

-1.9%

17.2M shares sold short in the report before, 16.9M on 30 Oct 2026

Short sale volume Share of the stock's latest daily volume on FINRA-reported off-exchange venues that was sold short. Market makers sell short routinely, so 40% to 50% is normal; compare it with the company's own 1-year average in the cell's details. A daily flow, not short interest.

19%

19% of off-exchange volume on 20 Nov 2026 was short sales; 1-year average 57%

Open jobs Job postings open on the company's own careers site today, where we track it. Blank when we do not track this company's careers site yet.

–

We do not track this company's careers site yet.

Open jobs change How the number of open job postings changed over the last 30 days: total hiring demand, any job, any country. Shown only once we have tracked the company for 30 days.

–

We do not track this company's careers site yet.

Employees Total staff the company reported in its latest annual report (10-K), with the change from the year before when both years are reported.

–

No headcount in its annual reports in our data.

Visa hiring (foreign workers) Applications to hire foreign specialists on H-1B and E-3 visas certified by the Labor Department in the last 12 months, compared with the 12 months before. This is NOT total hiring: most hires need no visa. Open jobs shows total hiring where we track it.

–

No data for this company

Revenue growth Sales in the latest reported quarter compared with the same quarter a year earlier.

–

No data for this company

Capital spending Money spent on buildings, machines and equipment in the latest quarter, compared with the same quarter a year earlier.

-91%

$219K vs $2.5M (quarter ended 30 Sep 2026)

Federal contracts Money the US government committed to the company in contracts and grants over the last 12 months.

–

No data for this company

Lobbying What the company reported spending on federal lobbying over the last four quarters.

–

No data for this company

Layoff notices Workers named in state WARN layoff notices over the last 12 months (employers must file them 60 days before a large layoff).

–

No data for this company

News (7d) Articles about the company published in the last 7 days, from our Google News collection (one search per company, every half hour). Blank when we do not collect news for this company.

24

24 articles in the last 7 days; its usual week has 3.5 (the median of the 26 weeks before).

News vs usual Articles in the last 7 days divided by the company's usual week: the median week of the 26 weeks before. Blank when the usual week has fewer than one article.

6.9×

24 articles in the last 7 days; its usual week has 3.5.

Price $2.42 on 20 Nov 2026, -43% over 12 months (12-month range $2.29 to $7.46)

  • Sharp change
  • 8-K and other filings
Insider net buying (open market). Insiders sold a net $3.5M in the last 12 months (the 12 months before: -$2.2M).
Revenue per quarter. Revenue $13.5M in the latest quarter.
Capital spending per quarter. Capital spending $219K in the latest quarter, -91% on a year earlier.
Institutional holders (13F filers). 114 13F filers reported holding it in the latest 13F quarter, +19% on a year earlier.

Every point sits on the day the fact became public (filing acceptance or publication), not the day it happened; prices through 20 Nov 2026. Hover or tap a marker for the fact; click it for the evidence or the source. No data here for: h-1b/e-3 applications certified, federal obligations, lobbying spend, workers in warn layoff notices.

See the numbers
Dated facts on the price chart (newest 100)
Became publicKindFact
9 Nov 20268-K and other filingsCompleted an acquisition or asset sale
20 Aug 2026Sharp changeQuarterly revenue change: quarterly revenue change, 11.4M vs usual 200K (2026-06-30); 28.4x the same period a year earlier
12 Jun 20268-K and other filingsDirector or officer change
7 Apr 20268-K and other filingsDirector or officer change
7 Apr 2026Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
28 Oct 2025Sharp changeShort interest spike: short interest spike, 9.2M vs usual 2.8M (2025-10-15); 3.3x the same period a year earlier
14 Oct 2025Sharp changeShort interest spike: short interest spike, 8.6M vs usual 2.7M (2025-09-30); 3.2x the same period a year earlier
30 Sep 2025Sharp changeShort interest spike: short interest spike, 8.7M vs usual 2.7M (2025-09-15); 3.3x the same period a year earlier
16 Sep 2025Sharp changeShort interest spike: short interest spike, 9.0M vs usual 2.7M (2025-08-29); 3.2x the same period a year earlier
2 Sep 2025Sharp changeShort interest spike: short interest spike, 8.8M vs usual 2.7M (2025-08-15); 2.9x the same period a year earlier
14 Aug 2025Sharp changeMany funds opening a new position: many funds opening a new position, 39 vs usual 11.50 (2025-06-30); 3.5x the same period a year earlier
12 Aug 2025Sharp changeShort interest spike: short interest spike, 8.4M vs usual 2.7M (2025-07-31); 2.8x the same period a year earlier
29 Jul 2025Sharp changeShort interest spike: short interest spike, 8.5M vs usual 2.7M (2025-07-15); 2.8x the same period a year earlier
2 Jul 20258-K and other filingsCompleted an acquisition or asset sale
1 Jul 2025Sharp changeShort interest spike: short interest spike, 6.5M vs usual 2.7M (2025-06-13); 2.4x the same period a year earlier
17 Jun 2025Sharp changeShort interest spike: short interest spike, 6.0M vs usual 2.6M (2025-05-30); 2.6x the same period a year earlier
3 Jun 2025Sharp changeShort interest spike: short interest spike, 5.9M vs usual 2.6M (2025-05-15); 2.0x the same period a year earlier
13 May 2025Sharp changeShort interest spike: short interest spike, 5.5M vs usual 2.6M (2025-04-30); 1.6x the same period a year earlier
20 Dec 20248-K and other filingsDirector or officer change
20 Dec 2024Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
14 Aug 20248-K and other filingsDirector or officer change
14 Aug 2024Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
13 Aug 2024Sharp changeShort interest spike: short interest spike, 3.0M vs usual 720K (2024-07-31); 5.5x the same period a year earlier
30 Jul 2024Sharp changeShort interest spike: short interest spike, 3.1M vs usual 702K (2024-07-15); 4.1x the same period a year earlier
16 Jul 2024Sharp changeShort interest spike: short interest spike, 3.4M vs usual 646K (2024-06-28); 6.3x the same period a year earlier
2 Jul 2024Sharp changeShort interest spike: short interest spike, 2.7M vs usual 625K (2024-06-14); 5.6x the same period a year earlier
18 Jun 2024Sharp changeShort interest spike: short interest spike, 2.3M vs usual 619K (2024-05-31); 5.3x the same period a year earlier
28 May 2024Sharp changeShort interest spike: short interest spike, 3.0M vs usual 611K (2024-05-15); 8.2x the same period a year earlier
14 May 2024Sharp changeShort interest spike: short interest spike, 3.3M vs usual 604K (2024-04-30); 6.5x the same period a year earlier
30 Apr 2024Sharp changeShort interest spike: short interest spike, 2.1M vs usual 603K (2024-04-15); 3.4x the same period a year earlier
30 Apr 2024Sharp changeClustered insider buying: clustered insider buying (4 independent filers, 4 filing(s) in 30 days, value_usd total 102K)
24 Apr 20248-K and other filingsDirector or officer change
24 Apr 2024Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
16 Apr 2024Sharp changeShort interest spike: short interest spike, 2.0M vs usual 603K (2024-03-28); 2.7x the same period a year earlier
2 Apr 2024Sharp changeShort interest spike: short interest spike, 1.7M vs usual 603K (2024-03-15); 2.8x the same period a year earlier
12 Mar 2024Sharp changeShort interest spike: short interest spike, 1.6M vs usual 601K (2024-02-29); 3.6x the same period a year earlier
5 Mar 2024Sharp changeShort interest spike: short interest spike, 1.6M vs usual 575K (2024-02-15); 3.6x the same period a year earlier
18 Oct 20238-K and other filingsChanged its auditor
30 Sep 2023Sharp changeClustered insider buying: clustered insider buying (3 independent filers, 3 filing(s) in 30 days, value_usd total 104K)
11 Apr 20238-K and other filingsDirector or officer change
11 Apr 2023Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
19 May 20228-K and other filingsDelisting notice or listing transfer
9 Mar 20228-K and other filingsDirector or officer change
9 Mar 2022Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
Insider net buying (open market)
Month from 1 Dec 2021: -$5K published
Month from 1 Jun 2022: -$9K published
Month from 1 Nov 2022: $40K published
Month from 1 Dec 2022: $18K published
Month from 1 Mar 2023: -$3K published
Month from 1 May 2023: -$3K published
Month from 1 Jun 2023: -$2K published
Month from 1 Sep 2023: -$37K published
Month from 1 Jan 2024: -$36K published
Month from 1 Feb 2024: $88K published
Month from 1 Apr 2024: $102K published
Month from 1 May 2024: $52K published
Month from 1 Jun 2024: -$233K published
Month from 1 Jan 2025: -$20K published
Month from 1 Feb 2025: -$22K published
Month from 1 Apr 2025: -$120K published
Month from 1 May 2025: -$58K published
Month from 1 Jun 2025: -$534K published
Month from 1 Jul 2025: -$914K published
Month from 1 Aug 2025: -$143K published
Month from 1 Sep 2025: -$4K published
Month from 1 Oct 2025: -$335K published
Month from 1 Nov 2025: -$71K published
Month from 1 Dec 2025: -$133K published
Month from 1 Jan 2026: -$681K published
Month from 1 Feb 2026: -$363K published
Month from 1 Mar 2026: -$4K published
Month from 1 Apr 2026: -$131K published
Month from 1 May 2026: -$213K published
Month from 1 Jun 2026: -$782K published
Month from 1 Jul 2026: -$893K published
Month from 1 Sep 2026: -$297K published
Month from 1 Nov 2026: $34K published
Revenue per quarter
Quarter ended 31 Mar 2022: $346K; public on 14 May 2022
Quarter ended 30 Jun 2022: $1.0M; public on 12 Aug 2022
Quarter ended 31 Dec 2022: $68K; public on 30 Mar 2023
Quarter ended 30 Jun 2023: $3.5M, +250% on a year earlier; public on 9 Aug 2023
Quarter ended 30 Sep 2023: $0; public on 14 Nov 2023
Quarter ended 31 Dec 2023: $0, -100% on a year earlier; public on 19 Mar 2024
Quarter ended 30 Jun 2025: $400K; public on 15 Aug 2025
Quarter ended 31 Dec 2025: $5.4M; public on 18 Mar 2026
Quarter ended 31 Mar 2026: $8.7M; public on 14 May 2026
Quarter ended 30 Jun 2026: $11.4M, +2745% on a year earlier; public on 14 Aug 2026
Quarter ended 30 Sep 2026: $13.5M; public on 10 Nov 2026
Capital spending per quarter
Quarter ended 31 Mar 2022: $103K, -77% on a year earlier; public on 14 May 2022
Quarter ended 31 Dec 2022: $25K; public on 30 Mar 2023
Quarter ended 31 Mar 2023: $218K, +112% on a year earlier; public on 12 May 2023
Quarter ended 30 Jun 2023: $32K; public on 9 Aug 2023
Quarter ended 30 Sep 2023: $44K; public on 14 Nov 2023
Quarter ended 31 Dec 2023: $37K, +48% on a year earlier; public on 19 Mar 2024
Quarter ended 31 Mar 2024: $725K, +233% on a year earlier; public on 16 May 2024
Quarter ended 30 Jun 2024: $711K, +2122% on a year earlier; public on 13 Aug 2024
Quarter ended 30 Sep 2024: $404K, +818% on a year earlier; public on 15 Nov 2024
Quarter ended 31 Dec 2024: $606K, +1538% on a year earlier; public on 21 Mar 2025
Quarter ended 31 Mar 2025: $1.4M, +93% on a year earlier; public on 16 May 2025
Quarter ended 30 Jun 2025: $2.9M, +308% on a year earlier; public on 15 Aug 2025
Quarter ended 30 Sep 2025: $2.5M, +524% on a year earlier; public on 13 Nov 2025
Quarter ended 31 Dec 2025: $1.2M, +90% on a year earlier; public on 18 Mar 2026
Quarter ended 31 Mar 2026: $935K, -33% on a year earlier; public on 14 May 2026
Quarter ended 30 Jun 2026: $479K, -83% on a year earlier; public on 14 Aug 2026
Quarter ended 30 Sep 2026: $219K, -91% on a year earlier; public on 10 Nov 2026
Institutional holders (13F filers)
31 Dec 2021 report: 51; public on 14 Feb 2022
31 Mar 2022 report: 51; public on 16 May 2022
30 Jun 2022 report: 38; public on 15 Aug 2022
30 Sep 2022 report: 22; public on 14 Nov 2022
31 Dec 2022 report: 38; public on 14 Feb 2023
31 Mar 2023 report: 33; public on 15 May 2023
30 Jun 2023 report: 35; public on 14 Aug 2023
30 Sep 2023 report: 36; public on 14 Nov 2023
31 Dec 2023 report: 46; public on 14 Feb 2024
31 Mar 2024 report: 54; public on 15 May 2024
30 Jun 2024 report: 45; public on 14 Aug 2024
30 Sep 2024 report: 53; public on 14 Nov 2024
31 Dec 2024 report: 63; public on 14 Feb 2025
31 Mar 2025 report: 68; public on 15 May 2025
30 Jun 2025 report: 92; public on 14 Aug 2025
30 Sep 2025 report: 96; public on 14 Nov 2025
31 Dec 2025 report: 100; public on 17 Feb 2026
31 Mar 2026 report: 105; public on 15 May 2026
30 Jun 2026 report: 126; public on 14 Aug 2026
30 Sep 2026 report: 114; public on 16 Nov 2026

What is unusual now

  • Nothing unusual in the last 90 days: no change appeared. Its most unusual measure now is insider open-market buying (USD, Form 4) at $34K (16 Nov 2026), higher than 88% of its own history.
  • Quarterly revenue change: reported revenue of $11.4M for the quarter ended 30 Jun 2026, 28× the same quarter last year Public on 20 Aug 2026.
  • Insider net buying (open market): Insiders sold a net $3.5M in the last 12 months (the 12 months before: -$2.2M).
  • Capital spending per quarter: Capital spending $219K in the latest quarter, -91% on a year earlier.

Latest records

The names and amounts behind the totals, newest first

Last 90 days: 5 sales, $297K; 1 purchase, $34K. Open-market trades by officers, directors and 10% owners.

FiledInsiderTradeSharesPriceValueSource
16 Nov 2026Faith L. CharlesDirectorBuy15,000$2.29$34KForm 4
29 Sep 2026Vishwas SeshadriChief Executive OfficerSell19,608$5.16$101KForm 4
29 Sep 2026Madhav VasanthavadaChief Commercial OfficerSell4,902$5.16$25KForm 4
29 Sep 2026Brendan M. O'MalleySVP, Chief Legal OfficerSell6,727$5.16$35KForm 4
29 Sep 2026Joseph Walter VazzanoChief Financial OfficerSell9,191$5.16$47KForm 4
1 Sep 2026Mark AlvinoDirectorSell15,000$5.86$88KForm 4
22 Jul 2026Joseph Walter VazzanoChief Financial OfficerSell1,478$6.53$10KForm 4
9 Jul 2026Vishwas SeshadriChief Executive OfficerSell67,971$6.96$473KForm 4

114 institutions reported shares at the end of Q3 2026, 71% of the shares outstanding; 11 opened a position, 23 sold out. From 13F reports.

InstitutionShares% of companyValueChange vs Q2 2026
Nantahala Capital Management, LLC5.4M9.47%$28.4M-4.9M-47%
Cable Car Capital, LP3.6M6.30%$18.9M+593K+20%
BlackRock, Inc.3.4M5.91%$17.7M+24K+0.7%
Rubric Capital Management LP3.3M5.84%$17.5M+2.7M+449%
AIGH Capital Management LLC2.9M5.07%$15.2M-87K-2.9%
Vanguard Capital Management LLC2.1M3.74%$11.2M-74K-3.3%
J. Goldman & Co LP1.5M2.65%$8.0M+839K+124%
AWM Investment Company, Inc.1.5M2.60%$7.8M+1,000+0.1%
Kennedy Capital Management LLC1.3M2.33%$7.0M+91K+7.3%
Geode Capital Management, LLC1.3M2.32%$7.0M+64K+5.1%

Company events

All 65 company events

In 12 months: 2 director or officer changes, 1 major agreement, 1 completed deal. Results releases and routine reports are left out.

FiledWhat happenedSource
9 Nov 2026Agreed to buy APT-1011 assets from Ellodi Pharmaceuticals, L.P. for $20M in stock, plus $30M on FDA approval and up to $30M in sales milestones; Completed an acquisition or asset saleSame filing: sold shares privately8-K
12 Jun 2026Director or officer change8-K
7 Apr 2026Director or officer change8-K
18 Jul 2025Signed a major agreementSame filing: took on new debt8-K
2 Jul 2025Completed an acquisition or asset sale8-K
12 May 2025Signed a major agreement8-K
20 Dec 2024Director or officer changeSame filing: shareholder vote results8-K
14 Aug 2024Director or officer change8-K

The 5 newest of 189 articles that name the company.

Timeline

Several things at once

Two or more unrelated kinds of records unusual within 30 days

14 Aug 2025confirmed

Confirmed across sources Institutional holdings and Short interest and volume

Abeona Therapeutics (ABEO): saw 39 13F filers open a new position in the quarter ended 30 Jun 2025, 3.5× the same quarter last year, while it had 9.2M shares sold short in the 15 Oct 2025 report, 3.3× the same report last year. Two unrelated kinds of activity within 91 days.

  • Short interest and volume: Short interest spike, became public on 25 Jul 2025
  • Short interest and volume: Short interest spike, became public on 12 Aug 2025
  • Institutional holdings: Many funds opening a new position, became public on 14 Aug 2025
  • Short interest and volume: Short interest spike, became public on 27 Aug 2025
  • Short interest and volume: Short interest spike, became public on 11 Sep 2025
  • Short interest and volume: Short interest spike, became public on 25 Sep 2025
  • Short interest and volume: Short interest spike, became public on 10 Oct 2025
  • Short interest and volume: Short interest spike, became public on 25 Oct 2025
2023-06-30: 92023-09-30: 72023-12-31: 132024-03-31: 142024-06-30: 112024-09-30: 92024-12-31: 122025-03-31: 132025-06-30: 39
The quarter ended 30 Jun 2025 against the 8 quarters before it. this quarterearliernormal: 11.5
See the evidence (8 changes)

Short interest and volume: Short interest spike became public on 25 Jul 2025

Abeona Therapeutics had 8.5M shares sold short in the 15 Jul 2025 report, 2.8× the same report last year.

This period
8.5M (the 15 Jul 2025 report)
Normal report (median of 24 earlier)
2.7M
Typical spread (median absolute deviation)
182K
How far from its usual level
+21.6
Same report last year
3.1M
History used
2,755 days
2024-07-15: 3.1M2024-07-31: 3.0M2024-08-15: 3.0M2024-08-30: 2.8M2024-09-13: 2.6M2024-09-30: 2.7M2024-10-15: 2.8M2024-10-31: 2.6M2024-11-15: 2.6M2024-11-29: 2.6M2024-12-13: 2.5M2024-12-31: 2.5M2025-01-15: 2.7M2025-01-31: 2.5M2025-02-14: 2.5M2025-02-28: 2.5M2025-03-14: 2.4M2025-03-31: 2.2M2025-04-15: 2.8M2025-04-30: 5.5M2025-05-15: 5.9M2025-05-30: 6.0M2025-06-13: 6.5M2025-06-30: 8.3M2025-07-15: 8.5M
the 15 Jul 2025 report24 earlier reportsnormal: 2.7M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Short interest and volume: Short interest spike became public on 12 Aug 2025

Abeona Therapeutics had 8.4M shares sold short in the 31 Jul 2025 report, 2.8× the same report last year.

This period
8.4M (the 31 Jul 2025 report)
Normal report (median of 24 earlier)
2.7M
Typical spread (median absolute deviation)
182K
How far from its usual level
+21.4
Same report last year
3.0M
History used
2,771 days
2024-07-31: 3.0M2024-08-15: 3.0M2024-08-30: 2.8M2024-09-13: 2.6M2024-09-30: 2.7M2024-10-15: 2.8M2024-10-31: 2.6M2024-11-15: 2.6M2024-11-29: 2.6M2024-12-13: 2.5M2024-12-31: 2.5M2025-01-15: 2.7M2025-01-31: 2.5M2025-02-14: 2.5M2025-02-28: 2.5M2025-03-14: 2.4M2025-03-31: 2.2M2025-04-15: 2.8M2025-04-30: 5.5M2025-05-15: 5.9M2025-05-30: 6.0M2025-06-13: 6.5M2025-06-30: 8.3M2025-07-15: 8.5M2025-07-31: 8.4M
the 31 Jul 2025 report24 earlier reportsnormal: 2.7M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Institutional holdings: Many funds opening a new position became public on 14 Aug 2025

Abeona Therapeutics saw 39 13F filers open a new position in the quarter ended 30 Jun 2025, 3.5× the same quarter last year.

This period
39 (the quarter ended 30 Jun 2025)
Normal quarter (median of 8 earlier)
11.5
Typical spread (median absolute deviation)
2
How far from its usual level
+9.2
Same quarter last year
11
History used
3,653 days
2023-06-30: 92023-09-30: 72023-12-31: 132024-03-31: 142024-06-30: 112024-09-30: 92024-12-31: 122025-03-31: 132025-06-30: 39
the quarter ended 30 Jun 20258 earlier quartersnormal: 11.5

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.

Check it at the source: SEC Form 13F data sets.

Short interest and volume: Short interest spike became public on 27 Aug 2025

Abeona Therapeutics had 8.8M shares sold short in the 15 Aug 2025 report, 2.9× the same report last year.

This period
8.8M (the 15 Aug 2025 report)
Normal report (median of 24 earlier)
2.7M
Typical spread (median absolute deviation)
182K
How far from its usual level
+22.8
Same report last year
3.0M
History used
2,786 days
2024-08-15: 3.0M2024-08-30: 2.8M2024-09-13: 2.6M2024-09-30: 2.7M2024-10-15: 2.8M2024-10-31: 2.6M2024-11-15: 2.6M2024-11-29: 2.6M2024-12-13: 2.5M2024-12-31: 2.5M2025-01-15: 2.7M2025-01-31: 2.5M2025-02-14: 2.5M2025-02-28: 2.5M2025-03-14: 2.4M2025-03-31: 2.2M2025-04-15: 2.8M2025-04-30: 5.5M2025-05-15: 5.9M2025-05-30: 6.0M2025-06-13: 6.5M2025-06-30: 8.3M2025-07-15: 8.5M2025-07-31: 8.4M2025-08-15: 8.8M
the 15 Aug 2025 report24 earlier reportsnormal: 2.7M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Short interest and volume: Short interest spike became public on 11 Sep 2025

Abeona Therapeutics had 9.0M shares sold short in the 29 Aug 2025 report, 3.2× the same report last year.

This period
9.0M (the 29 Aug 2025 report)
Normal report (median of 24 earlier)
2.7M
Typical spread (median absolute deviation)
182K
How far from its usual level
+23.6
Same report last year
2.8M
History used
2,800 days
2024-08-30: 2.8M2024-09-13: 2.6M2024-09-30: 2.7M2024-10-15: 2.8M2024-10-31: 2.6M2024-11-15: 2.6M2024-11-29: 2.6M2024-12-13: 2.5M2024-12-31: 2.5M2025-01-15: 2.7M2025-01-31: 2.5M2025-02-14: 2.5M2025-02-28: 2.5M2025-03-14: 2.4M2025-03-31: 2.2M2025-04-15: 2.8M2025-04-30: 5.5M2025-05-15: 5.9M2025-05-30: 6.0M2025-06-13: 6.5M2025-06-30: 8.3M2025-07-15: 8.5M2025-07-31: 8.4M2025-08-15: 8.8M2025-08-29: 9.0M
the 29 Aug 2025 report24 earlier reportsnormal: 2.7M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Short interest and volume: Short interest spike became public on 25 Sep 2025

Abeona Therapeutics had 8.7M shares sold short in the 15 Sep 2025 report, 3.3× the same report last year.

This period
8.7M (the 15 Sep 2025 report)
Normal report (median of 24 earlier)
2.7M
Typical spread (median absolute deviation)
191K
How far from its usual level
+21.4
Same report last year
2.6M
History used
2,817 days
2024-09-13: 2.6M2024-09-30: 2.7M2024-10-15: 2.8M2024-10-31: 2.6M2024-11-15: 2.6M2024-11-29: 2.6M2024-12-13: 2.5M2024-12-31: 2.5M2025-01-15: 2.7M2025-01-31: 2.5M2025-02-14: 2.5M2025-02-28: 2.5M2025-03-14: 2.4M2025-03-31: 2.2M2025-04-15: 2.8M2025-04-30: 5.5M2025-05-15: 5.9M2025-05-30: 6.0M2025-06-13: 6.5M2025-06-30: 8.3M2025-07-15: 8.5M2025-07-31: 8.4M2025-08-15: 8.8M2025-08-29: 9.0M2025-09-15: 8.7M
the 15 Sep 2025 report24 earlier reportsnormal: 2.7M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Short interest and volume: Short interest spike became public on 10 Oct 2025

Abeona Therapeutics had 8.6M shares sold short in the 30 Sep 2025 report, 3.2× the same report last year.

This period
8.6M (the 30 Sep 2025 report)
Normal report (median of 24 earlier)
2.7M
Typical spread (median absolute deviation)
286K
How far from its usual level
+13.9
Same report last year
2.7M
History used
2,832 days
2024-09-30: 2.7M2024-10-15: 2.8M2024-10-31: 2.6M2024-11-15: 2.6M2024-11-29: 2.6M2024-12-13: 2.5M2024-12-31: 2.5M2025-01-15: 2.7M2025-01-31: 2.5M2025-02-14: 2.5M2025-02-28: 2.5M2025-03-14: 2.4M2025-03-31: 2.2M2025-04-15: 2.8M2025-04-30: 5.5M2025-05-15: 5.9M2025-05-30: 6.0M2025-06-13: 6.5M2025-06-30: 8.3M2025-07-15: 8.5M2025-07-31: 8.4M2025-08-15: 8.8M2025-08-29: 9.0M2025-09-15: 8.7M2025-09-30: 8.6M
the 30 Sep 2025 report24 earlier reportsnormal: 2.7M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Short interest and volume: Short interest spike became public on 25 Oct 2025

Abeona Therapeutics had 9.2M shares sold short in the 15 Oct 2025 report, 3.3× the same report last year.

This period
9.2M (the 15 Oct 2025 report)
Normal report (median of 24 earlier)
2.8M
Typical spread (median absolute deviation)
465K
How far from its usual level
+9.3
Same report last year
2.8M
History used
2,847 days
2024-10-15: 2.8M2024-10-31: 2.6M2024-11-15: 2.6M2024-11-29: 2.6M2024-12-13: 2.5M2024-12-31: 2.5M2025-01-15: 2.7M2025-01-31: 2.5M2025-02-14: 2.5M2025-02-28: 2.5M2025-03-14: 2.4M2025-03-31: 2.2M2025-04-15: 2.8M2025-04-30: 5.5M2025-05-15: 5.9M2025-05-30: 6.0M2025-06-13: 6.5M2025-06-30: 8.3M2025-07-15: 8.5M2025-07-31: 8.4M2025-08-15: 8.8M2025-08-29: 9.0M2025-09-15: 8.7M2025-09-30: 8.6M2025-10-15: 9.2M
the 15 Oct 2025 report24 earlier reportsnormal: 2.8M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.

30 Apr 2024confirmed

Confirmed across sources Insiders and Short interest and volume

Abeona Therapeutics (ABEO): had 4 insiders buy $102K of its shares on the open market within 30 days (4 filings), while it had 3.4M shares sold short in the 28 Jun 2024 report, 6.3× the same report last year. Two unrelated kinds of activity within 133 days.

  • Short interest and volume: Short interest spike, became public on 27 Mar 2024
  • Short interest and volume: Short interest spike, became public on 10 Apr 2024
  • Insiders: Clustered insider buying, became public on 30 Apr 2024
  • Short interest and volume: Short interest spike, became public on 25 Apr 2024
  • Short interest and volume: Short interest spike, became public on 10 May 2024
  • Short interest and volume: Short interest spike, became public on 25 May 2024
  • Short interest and volume: Short interest spike, became public on 12 Jun 2024
  • Short interest and volume: Short interest spike, became public on 27 Jun 2024
  • Short interest and volume: Short interest spike, became public on 11 Jul 2024
  • Short interest and volume: Short interest spike, became public on 25 Jul 2024
  • Short interest and volume: Short interest spike, became public on 10 Aug 2024
2023-06-30: 536K2023-07-14: 742K2023-07-31: 538K2023-08-15: 442K2023-08-31: 501K2023-09-15: 601K2023-09-29: 619K2023-10-13: 618K2023-10-31: 630K2023-11-15: 604K2023-11-30: 549K2023-12-15: 429K2023-12-29: 604K2024-01-12: 662K2024-01-31: 778K2024-02-15: 1.6M2024-02-29: 1.6M2024-03-15: 1.7M2024-03-28: 2.0M2024-04-15: 2.1M2024-04-30: 3.3M2024-05-15: 3.0M2024-05-31: 2.3M2024-06-14: 2.7M2024-06-28: 3.4M
The 28 Jun 2024 report against the 24 reports before it. this reportearliernormal: 646K
See the evidence (11 changes)

Short interest and volume: Short interest spike became public on 27 Mar 2024

Abeona Therapeutics had 1.7M shares sold short in the 15 Mar 2024 report, 2.8× the same report last year.

This period
1.7M (the 15 Mar 2024 report)
Normal report (median of 24 earlier)
603K
Typical spread (median absolute deviation)
78K
How far from its usual level
+9.5
Same report last year
604K
History used
2,268 days
2023-03-15: 604K2023-03-31: 751K2023-04-14: 601K2023-04-28: 512K2023-05-15: 367K2023-05-31: 435K2023-06-15: 471K2023-06-30: 536K2023-07-14: 742K2023-07-31: 538K2023-08-15: 442K2023-08-31: 501K2023-09-15: 601K2023-09-29: 619K2023-10-13: 618K2023-10-31: 630K2023-11-15: 604K2023-11-30: 549K2023-12-15: 429K2023-12-29: 604K2024-01-12: 662K2024-01-31: 778K2024-02-15: 1.6M2024-02-29: 1.6M2024-03-15: 1.7M
the 15 Mar 2024 report24 earlier reportsnormal: 603K

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Short interest and volume: Short interest spike became public on 10 Apr 2024

Abeona Therapeutics had 2.0M shares sold short in the 28 Mar 2024 report, 2.7× the same report last year.

This period
2.0M (the 28 Mar 2024 report)
Normal report (median of 24 earlier)
603K
Typical spread (median absolute deviation)
96K
How far from its usual level
+9.8
Same report last year
751K
History used
2,281 days
2023-03-31: 751K2023-04-14: 601K2023-04-28: 512K2023-05-15: 367K2023-05-31: 435K2023-06-15: 471K2023-06-30: 536K2023-07-14: 742K2023-07-31: 538K2023-08-15: 442K2023-08-31: 501K2023-09-15: 601K2023-09-29: 619K2023-10-13: 618K2023-10-31: 630K2023-11-15: 604K2023-11-30: 549K2023-12-15: 429K2023-12-29: 604K2024-01-12: 662K2024-01-31: 778K2024-02-15: 1.6M2024-02-29: 1.6M2024-03-15: 1.7M2024-03-28: 2.0M
the 28 Mar 2024 report24 earlier reportsnormal: 603K

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Insiders: Clustered insider buying became public on 30 Apr 2024

Abeona Therapeutics had 4 insiders buy $102K of its shares on the open market within 30 days (4 filings).

Independent buyers
4
Purchase filings (Form 4, code P)
4
Total bought
$102K
Window
31 Mar 2024 to 30 Apr 2024

Fires when at least 3 independent insiders (joint filers count once) buy on the open market in 30 days, in at least 2 filings, for $100K or more in total; amendments do not count.

Short interest and volume: Short interest spike became public on 25 Apr 2024

Abeona Therapeutics had 2.1M shares sold short in the 15 Apr 2024 report, 3.4× the same report last year.

This period
2.1M (the 15 Apr 2024 report)
Normal report (median of 24 earlier)
603K
Typical spread (median absolute deviation)
96K
How far from its usual level
+10.2
Same report last year
601K
History used
2,299 days
2023-04-14: 601K2023-04-28: 512K2023-05-15: 367K2023-05-31: 435K2023-06-15: 471K2023-06-30: 536K2023-07-14: 742K2023-07-31: 538K2023-08-15: 442K2023-08-31: 501K2023-09-15: 601K2023-09-29: 619K2023-10-13: 618K2023-10-31: 630K2023-11-15: 604K2023-11-30: 549K2023-12-15: 429K2023-12-29: 604K2024-01-12: 662K2024-01-31: 778K2024-02-15: 1.6M2024-02-29: 1.6M2024-03-15: 1.7M2024-03-28: 2.0M2024-04-15: 2.1M
the 15 Apr 2024 report24 earlier reportsnormal: 603K

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Short interest and volume: Short interest spike became public on 10 May 2024

Abeona Therapeutics had 3.3M shares sold short in the 30 Apr 2024 report, 6.5× the same report last year.

This period
3.3M (the 30 Apr 2024 report)
Normal report (median of 24 earlier)
604K
Typical spread (median absolute deviation)
118K
How far from its usual level
+15.7
Same report last year
512K
History used
2,314 days
2023-04-28: 512K2023-05-15: 367K2023-05-31: 435K2023-06-15: 471K2023-06-30: 536K2023-07-14: 742K2023-07-31: 538K2023-08-15: 442K2023-08-31: 501K2023-09-15: 601K2023-09-29: 619K2023-10-13: 618K2023-10-31: 630K2023-11-15: 604K2023-11-30: 549K2023-12-15: 429K2023-12-29: 604K2024-01-12: 662K2024-01-31: 778K2024-02-15: 1.6M2024-02-29: 1.6M2024-03-15: 1.7M2024-03-28: 2.0M2024-04-15: 2.1M2024-04-30: 3.3M
the 30 Apr 2024 report24 earlier reportsnormal: 604K

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Short interest and volume: Short interest spike became public on 25 May 2024

Abeona Therapeutics had 3.0M shares sold short in the 15 May 2024 report, 8.2× the same report last year.

This period
3.0M (the 15 May 2024 report)
Normal report (median of 24 earlier)
611K
Typical spread (median absolute deviation)
136K
How far from its usual level
+12.0
Same report last year
367K
History used
2,329 days
2023-05-15: 367K2023-05-31: 435K2023-06-15: 471K2023-06-30: 536K2023-07-14: 742K2023-07-31: 538K2023-08-15: 442K2023-08-31: 501K2023-09-15: 601K2023-09-29: 619K2023-10-13: 618K2023-10-31: 630K2023-11-15: 604K2023-11-30: 549K2023-12-15: 429K2023-12-29: 604K2024-01-12: 662K2024-01-31: 778K2024-02-15: 1.6M2024-02-29: 1.6M2024-03-15: 1.7M2024-03-28: 2.0M2024-04-15: 2.1M2024-04-30: 3.3M2024-05-15: 3.0M
the 15 May 2024 report24 earlier reportsnormal: 611K

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Short interest and volume: Short interest spike became public on 12 Jun 2024

Abeona Therapeutics had 2.3M shares sold short in the 31 May 2024 report, 5.3× the same report last year.

This period
2.3M (the 31 May 2024 report)
Normal report (median of 24 earlier)
619K
Typical spread (median absolute deviation)
136K
How far from its usual level
+8.3
Same report last year
435K
History used
2,345 days
2023-05-31: 435K2023-06-15: 471K2023-06-30: 536K2023-07-14: 742K2023-07-31: 538K2023-08-15: 442K2023-08-31: 501K2023-09-15: 601K2023-09-29: 619K2023-10-13: 618K2023-10-31: 630K2023-11-15: 604K2023-11-30: 549K2023-12-15: 429K2023-12-29: 604K2024-01-12: 662K2024-01-31: 778K2024-02-15: 1.6M2024-02-29: 1.6M2024-03-15: 1.7M2024-03-28: 2.0M2024-04-15: 2.1M2024-04-30: 3.3M2024-05-15: 3.0M2024-05-31: 2.3M
the 31 May 2024 report24 earlier reportsnormal: 619K

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Short interest and volume: Short interest spike became public on 27 Jun 2024

Abeona Therapeutics had 2.7M shares sold short in the 14 Jun 2024 report, 5.6× the same report last year.

This period
2.7M (the 14 Jun 2024 report)
Normal report (median of 24 earlier)
625K
Typical spread (median absolute deviation)
139K
How far from its usual level
+9.9
Same report last year
471K
History used
2,359 days
2023-06-15: 471K2023-06-30: 536K2023-07-14: 742K2023-07-31: 538K2023-08-15: 442K2023-08-31: 501K2023-09-15: 601K2023-09-29: 619K2023-10-13: 618K2023-10-31: 630K2023-11-15: 604K2023-11-30: 549K2023-12-15: 429K2023-12-29: 604K2024-01-12: 662K2024-01-31: 778K2024-02-15: 1.6M2024-02-29: 1.6M2024-03-15: 1.7M2024-03-28: 2.0M2024-04-15: 2.1M2024-04-30: 3.3M2024-05-15: 3.0M2024-05-31: 2.3M2024-06-14: 2.7M
the 14 Jun 2024 report24 earlier reportsnormal: 625K

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Short interest and volume: Short interest spike became public on 11 Jul 2024

Abeona Therapeutics had 3.4M shares sold short in the 28 Jun 2024 report, 6.3× the same report last year.

This period
3.4M (the 28 Jun 2024 report)
Normal report (median of 24 earlier)
646K
Typical spread (median absolute deviation)
139K
How far from its usual level
+13.2
Same report last year
536K
History used
2,373 days
2023-06-30: 536K2023-07-14: 742K2023-07-31: 538K2023-08-15: 442K2023-08-31: 501K2023-09-15: 601K2023-09-29: 619K2023-10-13: 618K2023-10-31: 630K2023-11-15: 604K2023-11-30: 549K2023-12-15: 429K2023-12-29: 604K2024-01-12: 662K2024-01-31: 778K2024-02-15: 1.6M2024-02-29: 1.6M2024-03-15: 1.7M2024-03-28: 2.0M2024-04-15: 2.1M2024-04-30: 3.3M2024-05-15: 3.0M2024-05-31: 2.3M2024-06-14: 2.7M2024-06-28: 3.4M
the 28 Jun 2024 report24 earlier reportsnormal: 646K

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Short interest and volume: Short interest spike became public on 25 Jul 2024

Abeona Therapeutics had 3.1M shares sold short in the 15 Jul 2024 report, 4.1× the same report last year.

This period
3.1M (the 15 Jul 2024 report)
Normal report (median of 24 earlier)
702K
Typical spread (median absolute deviation)
231K
How far from its usual level
+6.9
Same report last year
742K
History used
2,390 days
2023-07-14: 742K2023-07-31: 538K2023-08-15: 442K2023-08-31: 501K2023-09-15: 601K2023-09-29: 619K2023-10-13: 618K2023-10-31: 630K2023-11-15: 604K2023-11-30: 549K2023-12-15: 429K2023-12-29: 604K2024-01-12: 662K2024-01-31: 778K2024-02-15: 1.6M2024-02-29: 1.6M2024-03-15: 1.7M2024-03-28: 2.0M2024-04-15: 2.1M2024-04-30: 3.3M2024-05-15: 3.0M2024-05-31: 2.3M2024-06-14: 2.7M2024-06-28: 3.4M2024-07-15: 3.1M
the 15 Jul 2024 report24 earlier reportsnormal: 702K

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Short interest and volume: Short interest spike became public on 10 Aug 2024

Abeona Therapeutics had 3.0M shares sold short in the 31 Jul 2024 report, 5.5× the same report last year.

This period
3.0M (the 31 Jul 2024 report)
Normal report (median of 24 earlier)
720K
Typical spread (median absolute deviation)
285K
How far from its usual level
+5.3
Same report last year
538K
History used
2,406 days
2023-07-31: 538K2023-08-15: 442K2023-08-31: 501K2023-09-15: 601K2023-09-29: 619K2023-10-13: 618K2023-10-31: 630K2023-11-15: 604K2023-11-30: 549K2023-12-15: 429K2023-12-29: 604K2024-01-12: 662K2024-01-31: 778K2024-02-15: 1.6M2024-02-29: 1.6M2024-03-15: 1.7M2024-03-28: 2.0M2024-04-15: 2.1M2024-04-30: 3.3M2024-05-15: 3.0M2024-05-31: 2.3M2024-06-14: 2.7M2024-06-28: 3.4M2024-07-15: 3.1M2024-07-31: 3.0M
the 31 Jul 2024 report24 earlier reportsnormal: 720K

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.

Timeline

Changes and notable records, by the date each became public

  1. 16 Nov 2026Insiders record

    Charles Faith L. (director) bought 15,000 shares of ABEO ($34,348)

  2. 9 Nov 2026Filings record

    Completed an acquisition or asset sale

  3. 20 Aug 2026Financials change

    reported revenue of $11.4M for the quarter ended 30 Jun 2026, 28× the same quarter last year.

    Same quarter last year: $400K; its normal quarter is $200K.

    See the evidence
    This period
    $11.4M (the quarter ended 30 Jun 2026)
    Normal quarter (median of 6 earlier)
    $200K
    Typical spread (median absolute deviation)
    $200K
    How far from its usual level
    +11.2
    Same quarter last year
    $400K
    History used
    3,743 days
    2023-09-30: $02023-12-31: $02025-06-30: $400K2025-09-30: $02025-12-31: $5.4M2026-03-31: $8.7M2026-06-30: $11.4M
    the quarter ended 30 Jun 20266 earlier quartersnormal: $200K

    Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $10.0M.

    Check it at the source: SEC EDGAR quarterly reports.

  4. 12 Jun 2026Filings record

    Director or officer change

  5. 7 Apr 2026Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  6. 7 Apr 2026Filings record

    Director or officer change

  7. 25 Oct 2025Short interest and volume change

    had 9.2M shares sold short in the 15 Oct 2025 report, 3.3× the same report last year.

    Same report last year: 2.8M; its normal report is 2.8M.

    See the evidence
    This period
    9.2M (the 15 Oct 2025 report)
    Normal report (median of 24 earlier)
    2.8M
    Typical spread (median absolute deviation)
    465K
    How far from its usual level
    +9.3
    Same report last year
    2.8M
    History used
    2,847 days
    2024-10-15: 2.8M2024-10-31: 2.6M2024-11-15: 2.6M2024-11-29: 2.6M2024-12-13: 2.5M2024-12-31: 2.5M2025-01-15: 2.7M2025-01-31: 2.5M2025-02-14: 2.5M2025-02-28: 2.5M2025-03-14: 2.4M2025-03-31: 2.2M2025-04-15: 2.8M2025-04-30: 5.5M2025-05-15: 5.9M2025-05-30: 6.0M2025-06-13: 6.5M2025-06-30: 8.3M2025-07-15: 8.5M2025-07-31: 8.4M2025-08-15: 8.8M2025-08-29: 9.0M2025-09-15: 8.7M2025-09-30: 8.6M2025-10-15: 9.2M
    the 15 Oct 2025 report24 earlier reportsnormal: 2.8M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  8. 10 Oct 2025Short interest and volume change

    had 8.6M shares sold short in the 30 Sep 2025 report, 3.2× the same report last year.

    Same report last year: 2.7M; its normal report is 2.7M.

    See the evidence
    This period
    8.6M (the 30 Sep 2025 report)
    Normal report (median of 24 earlier)
    2.7M
    Typical spread (median absolute deviation)
    286K
    How far from its usual level
    +13.9
    Same report last year
    2.7M
    History used
    2,832 days
    2024-09-30: 2.7M2024-10-15: 2.8M2024-10-31: 2.6M2024-11-15: 2.6M2024-11-29: 2.6M2024-12-13: 2.5M2024-12-31: 2.5M2025-01-15: 2.7M2025-01-31: 2.5M2025-02-14: 2.5M2025-02-28: 2.5M2025-03-14: 2.4M2025-03-31: 2.2M2025-04-15: 2.8M2025-04-30: 5.5M2025-05-15: 5.9M2025-05-30: 6.0M2025-06-13: 6.5M2025-06-30: 8.3M2025-07-15: 8.5M2025-07-31: 8.4M2025-08-15: 8.8M2025-08-29: 9.0M2025-09-15: 8.7M2025-09-30: 8.6M
    the 30 Sep 2025 report24 earlier reportsnormal: 2.7M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  9. 25 Sep 2025Short interest and volume change

    had 8.7M shares sold short in the 15 Sep 2025 report, 3.3× the same report last year.

    Same report last year: 2.6M; its normal report is 2.7M.

    See the evidence
    This period
    8.7M (the 15 Sep 2025 report)
    Normal report (median of 24 earlier)
    2.7M
    Typical spread (median absolute deviation)
    191K
    How far from its usual level
    +21.4
    Same report last year
    2.6M
    History used
    2,817 days
    2024-09-13: 2.6M2024-09-30: 2.7M2024-10-15: 2.8M2024-10-31: 2.6M2024-11-15: 2.6M2024-11-29: 2.6M2024-12-13: 2.5M2024-12-31: 2.5M2025-01-15: 2.7M2025-01-31: 2.5M2025-02-14: 2.5M2025-02-28: 2.5M2025-03-14: 2.4M2025-03-31: 2.2M2025-04-15: 2.8M2025-04-30: 5.5M2025-05-15: 5.9M2025-05-30: 6.0M2025-06-13: 6.5M2025-06-30: 8.3M2025-07-15: 8.5M2025-07-31: 8.4M2025-08-15: 8.8M2025-08-29: 9.0M2025-09-15: 8.7M
    the 15 Sep 2025 report24 earlier reportsnormal: 2.7M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  10. 11 Sep 2025Short interest and volume change

    had 9.0M shares sold short in the 29 Aug 2025 report, 3.2× the same report last year.

    Same report last year: 2.8M; its normal report is 2.7M.

    See the evidence
    This period
    9.0M (the 29 Aug 2025 report)
    Normal report (median of 24 earlier)
    2.7M
    Typical spread (median absolute deviation)
    182K
    How far from its usual level
    +23.6
    Same report last year
    2.8M
    History used
    2,800 days
    2024-08-30: 2.8M2024-09-13: 2.6M2024-09-30: 2.7M2024-10-15: 2.8M2024-10-31: 2.6M2024-11-15: 2.6M2024-11-29: 2.6M2024-12-13: 2.5M2024-12-31: 2.5M2025-01-15: 2.7M2025-01-31: 2.5M2025-02-14: 2.5M2025-02-28: 2.5M2025-03-14: 2.4M2025-03-31: 2.2M2025-04-15: 2.8M2025-04-30: 5.5M2025-05-15: 5.9M2025-05-30: 6.0M2025-06-13: 6.5M2025-06-30: 8.3M2025-07-15: 8.5M2025-07-31: 8.4M2025-08-15: 8.8M2025-08-29: 9.0M
    the 29 Aug 2025 report24 earlier reportsnormal: 2.7M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  11. 27 Aug 2025Short interest and volume change

    had 8.8M shares sold short in the 15 Aug 2025 report, 2.9× the same report last year.

    Same report last year: 3.0M; its normal report is 2.7M.

    See the evidence
    This period
    8.8M (the 15 Aug 2025 report)
    Normal report (median of 24 earlier)
    2.7M
    Typical spread (median absolute deviation)
    182K
    How far from its usual level
    +22.8
    Same report last year
    3.0M
    History used
    2,786 days
    2024-08-15: 3.0M2024-08-30: 2.8M2024-09-13: 2.6M2024-09-30: 2.7M2024-10-15: 2.8M2024-10-31: 2.6M2024-11-15: 2.6M2024-11-29: 2.6M2024-12-13: 2.5M2024-12-31: 2.5M2025-01-15: 2.7M2025-01-31: 2.5M2025-02-14: 2.5M2025-02-28: 2.5M2025-03-14: 2.4M2025-03-31: 2.2M2025-04-15: 2.8M2025-04-30: 5.5M2025-05-15: 5.9M2025-05-30: 6.0M2025-06-13: 6.5M2025-06-30: 8.3M2025-07-15: 8.5M2025-07-31: 8.4M2025-08-15: 8.8M
    the 15 Aug 2025 report24 earlier reportsnormal: 2.7M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  12. 14 Aug 2025several at once

    saw 39 13F filers open a new position in the quarter ended 30 Jun 2025, 3.5× the same quarter last year, while it had 9.2M shares sold short in the 15 Oct 2025 report, 3.3× the same report last year. Two unrelated kinds of activity within 91 days.

    See the evidence (8 changes)

    Short interest and volume: Short interest spike became public on 25 Jul 2025

    Abeona Therapeutics had 8.5M shares sold short in the 15 Jul 2025 report, 2.8× the same report last year.

    This period
    8.5M (the 15 Jul 2025 report)
    Normal report (median of 24 earlier)
    2.7M
    Typical spread (median absolute deviation)
    182K
    How far from its usual level
    +21.6
    Same report last year
    3.1M
    History used
    2,755 days
    2024-07-15: 3.1M2024-07-31: 3.0M2024-08-15: 3.0M2024-08-30: 2.8M2024-09-13: 2.6M2024-09-30: 2.7M2024-10-15: 2.8M2024-10-31: 2.6M2024-11-15: 2.6M2024-11-29: 2.6M2024-12-13: 2.5M2024-12-31: 2.5M2025-01-15: 2.7M2025-01-31: 2.5M2025-02-14: 2.5M2025-02-28: 2.5M2025-03-14: 2.4M2025-03-31: 2.2M2025-04-15: 2.8M2025-04-30: 5.5M2025-05-15: 5.9M2025-05-30: 6.0M2025-06-13: 6.5M2025-06-30: 8.3M2025-07-15: 8.5M
    the 15 Jul 2025 report24 earlier reportsnormal: 2.7M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

    Short interest and volume: Short interest spike became public on 12 Aug 2025

    Abeona Therapeutics had 8.4M shares sold short in the 31 Jul 2025 report, 2.8× the same report last year.

    This period
    8.4M (the 31 Jul 2025 report)
    Normal report (median of 24 earlier)
    2.7M
    Typical spread (median absolute deviation)
    182K
    How far from its usual level
    +21.4
    Same report last year
    3.0M
    History used
    2,771 days
    2024-07-31: 3.0M2024-08-15: 3.0M2024-08-30: 2.8M2024-09-13: 2.6M2024-09-30: 2.7M2024-10-15: 2.8M2024-10-31: 2.6M2024-11-15: 2.6M2024-11-29: 2.6M2024-12-13: 2.5M2024-12-31: 2.5M2025-01-15: 2.7M2025-01-31: 2.5M2025-02-14: 2.5M2025-02-28: 2.5M2025-03-14: 2.4M2025-03-31: 2.2M2025-04-15: 2.8M2025-04-30: 5.5M2025-05-15: 5.9M2025-05-30: 6.0M2025-06-13: 6.5M2025-06-30: 8.3M2025-07-15: 8.5M2025-07-31: 8.4M
    the 31 Jul 2025 report24 earlier reportsnormal: 2.7M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

    Institutional holdings: Many funds opening a new position became public on 14 Aug 2025

    Abeona Therapeutics saw 39 13F filers open a new position in the quarter ended 30 Jun 2025, 3.5× the same quarter last year.

    This period
    39 (the quarter ended 30 Jun 2025)
    Normal quarter (median of 8 earlier)
    11.5
    Typical spread (median absolute deviation)
    2
    How far from its usual level
    +9.2
    Same quarter last year
    11
    History used
    3,653 days
    2023-06-30: 92023-09-30: 72023-12-31: 132024-03-31: 142024-06-30: 112024-09-30: 92024-12-31: 122025-03-31: 132025-06-30: 39
    the quarter ended 30 Jun 20258 earlier quartersnormal: 11.5

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.

    Check it at the source: SEC Form 13F data sets.

    Short interest and volume: Short interest spike became public on 27 Aug 2025

    Abeona Therapeutics had 8.8M shares sold short in the 15 Aug 2025 report, 2.9× the same report last year.

    This period
    8.8M (the 15 Aug 2025 report)
    Normal report (median of 24 earlier)
    2.7M
    Typical spread (median absolute deviation)
    182K
    How far from its usual level
    +22.8
    Same report last year
    3.0M
    History used
    2,786 days
    2024-08-15: 3.0M2024-08-30: 2.8M2024-09-13: 2.6M2024-09-30: 2.7M2024-10-15: 2.8M2024-10-31: 2.6M2024-11-15: 2.6M2024-11-29: 2.6M2024-12-13: 2.5M2024-12-31: 2.5M2025-01-15: 2.7M2025-01-31: 2.5M2025-02-14: 2.5M2025-02-28: 2.5M2025-03-14: 2.4M2025-03-31: 2.2M2025-04-15: 2.8M2025-04-30: 5.5M2025-05-15: 5.9M2025-05-30: 6.0M2025-06-13: 6.5M2025-06-30: 8.3M2025-07-15: 8.5M2025-07-31: 8.4M2025-08-15: 8.8M
    the 15 Aug 2025 report24 earlier reportsnormal: 2.7M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

    Short interest and volume: Short interest spike became public on 11 Sep 2025

    Abeona Therapeutics had 9.0M shares sold short in the 29 Aug 2025 report, 3.2× the same report last year.

    This period
    9.0M (the 29 Aug 2025 report)
    Normal report (median of 24 earlier)
    2.7M
    Typical spread (median absolute deviation)
    182K
    How far from its usual level
    +23.6
    Same report last year
    2.8M
    History used
    2,800 days
    2024-08-30: 2.8M2024-09-13: 2.6M2024-09-30: 2.7M2024-10-15: 2.8M2024-10-31: 2.6M2024-11-15: 2.6M2024-11-29: 2.6M2024-12-13: 2.5M2024-12-31: 2.5M2025-01-15: 2.7M2025-01-31: 2.5M2025-02-14: 2.5M2025-02-28: 2.5M2025-03-14: 2.4M2025-03-31: 2.2M2025-04-15: 2.8M2025-04-30: 5.5M2025-05-15: 5.9M2025-05-30: 6.0M2025-06-13: 6.5M2025-06-30: 8.3M2025-07-15: 8.5M2025-07-31: 8.4M2025-08-15: 8.8M2025-08-29: 9.0M
    the 29 Aug 2025 report24 earlier reportsnormal: 2.7M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

    Short interest and volume: Short interest spike became public on 25 Sep 2025

    Abeona Therapeutics had 8.7M shares sold short in the 15 Sep 2025 report, 3.3× the same report last year.

    This period
    8.7M (the 15 Sep 2025 report)
    Normal report (median of 24 earlier)
    2.7M
    Typical spread (median absolute deviation)
    191K
    How far from its usual level
    +21.4
    Same report last year
    2.6M
    History used
    2,817 days
    2024-09-13: 2.6M2024-09-30: 2.7M2024-10-15: 2.8M2024-10-31: 2.6M2024-11-15: 2.6M2024-11-29: 2.6M2024-12-13: 2.5M2024-12-31: 2.5M2025-01-15: 2.7M2025-01-31: 2.5M2025-02-14: 2.5M2025-02-28: 2.5M2025-03-14: 2.4M2025-03-31: 2.2M2025-04-15: 2.8M2025-04-30: 5.5M2025-05-15: 5.9M2025-05-30: 6.0M2025-06-13: 6.5M2025-06-30: 8.3M2025-07-15: 8.5M2025-07-31: 8.4M2025-08-15: 8.8M2025-08-29: 9.0M2025-09-15: 8.7M
    the 15 Sep 2025 report24 earlier reportsnormal: 2.7M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

    Short interest and volume: Short interest spike became public on 10 Oct 2025

    Abeona Therapeutics had 8.6M shares sold short in the 30 Sep 2025 report, 3.2× the same report last year.

    This period
    8.6M (the 30 Sep 2025 report)
    Normal report (median of 24 earlier)
    2.7M
    Typical spread (median absolute deviation)
    286K
    How far from its usual level
    +13.9
    Same report last year
    2.7M
    History used
    2,832 days
    2024-09-30: 2.7M2024-10-15: 2.8M2024-10-31: 2.6M2024-11-15: 2.6M2024-11-29: 2.6M2024-12-13: 2.5M2024-12-31: 2.5M2025-01-15: 2.7M2025-01-31: 2.5M2025-02-14: 2.5M2025-02-28: 2.5M2025-03-14: 2.4M2025-03-31: 2.2M2025-04-15: 2.8M2025-04-30: 5.5M2025-05-15: 5.9M2025-05-30: 6.0M2025-06-13: 6.5M2025-06-30: 8.3M2025-07-15: 8.5M2025-07-31: 8.4M2025-08-15: 8.8M2025-08-29: 9.0M2025-09-15: 8.7M2025-09-30: 8.6M
    the 30 Sep 2025 report24 earlier reportsnormal: 2.7M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

    Short interest and volume: Short interest spike became public on 25 Oct 2025

    Abeona Therapeutics had 9.2M shares sold short in the 15 Oct 2025 report, 3.3× the same report last year.

    This period
    9.2M (the 15 Oct 2025 report)
    Normal report (median of 24 earlier)
    2.8M
    Typical spread (median absolute deviation)
    465K
    How far from its usual level
    +9.3
    Same report last year
    2.8M
    History used
    2,847 days
    2024-10-15: 2.8M2024-10-31: 2.6M2024-11-15: 2.6M2024-11-29: 2.6M2024-12-13: 2.5M2024-12-31: 2.5M2025-01-15: 2.7M2025-01-31: 2.5M2025-02-14: 2.5M2025-02-28: 2.5M2025-03-14: 2.4M2025-03-31: 2.2M2025-04-15: 2.8M2025-04-30: 5.5M2025-05-15: 5.9M2025-05-30: 6.0M2025-06-13: 6.5M2025-06-30: 8.3M2025-07-15: 8.5M2025-07-31: 8.4M2025-08-15: 8.8M2025-08-29: 9.0M2025-09-15: 8.7M2025-09-30: 8.6M2025-10-15: 9.2M
    the 15 Oct 2025 report24 earlier reportsnormal: 2.8M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

    Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.

  13. 14 Aug 2025Institutional holdings change

    saw 39 13F filers open a new position in the quarter ended 30 Jun 2025, 3.5× the same quarter last year.

    Same quarter last year: 11; its normal quarter is 11.5.

    See the evidence
    This period
    39 (the quarter ended 30 Jun 2025)
    Normal quarter (median of 8 earlier)
    11.5
    Typical spread (median absolute deviation)
    2
    How far from its usual level
    +9.2
    Same quarter last year
    11
    History used
    3,653 days
    2023-06-30: 92023-09-30: 72023-12-31: 132024-03-31: 142024-06-30: 112024-09-30: 92024-12-31: 122025-03-31: 132025-06-30: 39
    the quarter ended 30 Jun 20258 earlier quartersnormal: 11.5

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.

    Check it at the source: SEC Form 13F data sets.

  14. 12 Aug 2025Short interest and volume change

    had 8.4M shares sold short in the 31 Jul 2025 report, 2.8× the same report last year.

    Same report last year: 3.0M; its normal report is 2.7M.

    See the evidence
    This period
    8.4M (the 31 Jul 2025 report)
    Normal report (median of 24 earlier)
    2.7M
    Typical spread (median absolute deviation)
    182K
    How far from its usual level
    +21.4
    Same report last year
    3.0M
    History used
    2,771 days
    2024-07-31: 3.0M2024-08-15: 3.0M2024-08-30: 2.8M2024-09-13: 2.6M2024-09-30: 2.7M2024-10-15: 2.8M2024-10-31: 2.6M2024-11-15: 2.6M2024-11-29: 2.6M2024-12-13: 2.5M2024-12-31: 2.5M2025-01-15: 2.7M2025-01-31: 2.5M2025-02-14: 2.5M2025-02-28: 2.5M2025-03-14: 2.4M2025-03-31: 2.2M2025-04-15: 2.8M2025-04-30: 5.5M2025-05-15: 5.9M2025-05-30: 6.0M2025-06-13: 6.5M2025-06-30: 8.3M2025-07-15: 8.5M2025-07-31: 8.4M
    the 31 Jul 2025 report24 earlier reportsnormal: 2.7M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  15. 25 Jul 2025Short interest and volume change

    had 8.5M shares sold short in the 15 Jul 2025 report, 2.8× the same report last year.

    Same report last year: 3.1M; its normal report is 2.7M.

    See the evidence
    This period
    8.5M (the 15 Jul 2025 report)
    Normal report (median of 24 earlier)
    2.7M
    Typical spread (median absolute deviation)
    182K
    How far from its usual level
    +21.6
    Same report last year
    3.1M
    History used
    2,755 days
    2024-07-15: 3.1M2024-07-31: 3.0M2024-08-15: 3.0M2024-08-30: 2.8M2024-09-13: 2.6M2024-09-30: 2.7M2024-10-15: 2.8M2024-10-31: 2.6M2024-11-15: 2.6M2024-11-29: 2.6M2024-12-13: 2.5M2024-12-31: 2.5M2025-01-15: 2.7M2025-01-31: 2.5M2025-02-14: 2.5M2025-02-28: 2.5M2025-03-14: 2.4M2025-03-31: 2.2M2025-04-15: 2.8M2025-04-30: 5.5M2025-05-15: 5.9M2025-05-30: 6.0M2025-06-13: 6.5M2025-06-30: 8.3M2025-07-15: 8.5M
    the 15 Jul 2025 report24 earlier reportsnormal: 2.7M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  16. 2 Jul 2025Filings record

    Completed an acquisition or asset sale

  17. 26 Jun 2025Short interest and volume change

    had 6.5M shares sold short in the 13 Jun 2025 report, 2.4× the same report last year.

    Same report last year: 2.7M; its normal report is 2.7M.

    See the evidence
    This period
    6.5M (the 13 Jun 2025 report)
    Normal report (median of 24 earlier)
    2.7M
    Typical spread (median absolute deviation)
    157K
    How far from its usual level
    +14.3
    Same report last year
    2.7M
    History used
    2,723 days
    2024-06-14: 2.7M2024-06-28: 3.4M2024-07-15: 3.1M2024-07-31: 3.0M2024-08-15: 3.0M2024-08-30: 2.8M2024-09-13: 2.6M2024-09-30: 2.7M2024-10-15: 2.8M2024-10-31: 2.6M2024-11-15: 2.6M2024-11-29: 2.6M2024-12-13: 2.5M2024-12-31: 2.5M2025-01-15: 2.7M2025-01-31: 2.5M2025-02-14: 2.5M2025-02-28: 2.5M2025-03-14: 2.4M2025-03-31: 2.2M2025-04-15: 2.8M2025-04-30: 5.5M2025-05-15: 5.9M2025-05-30: 6.0M2025-06-13: 6.5M
    the 13 Jun 2025 report24 earlier reportsnormal: 2.7M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  18. 11 Jun 2025Short interest and volume change

    had 6.0M shares sold short in the 30 May 2025 report, 2.6× the same report last year.

    Same report last year: 2.3M; its normal report is 2.6M.

    See the evidence
    This period
    6.0M (the 30 May 2025 report)
    Normal report (median of 24 earlier)
    2.6M
    Typical spread (median absolute deviation)
    145K
    How far from its usual level
    +12.7
    Same report last year
    2.3M
    History used
    2,709 days
    2024-05-31: 2.3M2024-06-14: 2.7M2024-06-28: 3.4M2024-07-15: 3.1M2024-07-31: 3.0M2024-08-15: 3.0M2024-08-30: 2.8M2024-09-13: 2.6M2024-09-30: 2.7M2024-10-15: 2.8M2024-10-31: 2.6M2024-11-15: 2.6M2024-11-29: 2.6M2024-12-13: 2.5M2024-12-31: 2.5M2025-01-15: 2.7M2025-01-31: 2.5M2025-02-14: 2.5M2025-02-28: 2.5M2025-03-14: 2.4M2025-03-31: 2.2M2025-04-15: 2.8M2025-04-30: 5.5M2025-05-15: 5.9M2025-05-30: 6.0M
    the 30 May 2025 report24 earlier reportsnormal: 2.6M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  19. 28 May 2025Short interest and volume change

    had 5.9M shares sold short in the 15 May 2025 report, 2.0× the same report last year.

    Same report last year: 3.0M; its normal report is 2.6M.

    See the evidence
    This period
    5.9M (the 15 May 2025 report)
    Normal report (median of 24 earlier)
    2.6M
    Typical spread (median absolute deviation)
    145K
    How far from its usual level
    +12.3
    Same report last year
    3.0M
    History used
    2,694 days
    2024-05-15: 3.0M2024-05-31: 2.3M2024-06-14: 2.7M2024-06-28: 3.4M2024-07-15: 3.1M2024-07-31: 3.0M2024-08-15: 3.0M2024-08-30: 2.8M2024-09-13: 2.6M2024-09-30: 2.7M2024-10-15: 2.8M2024-10-31: 2.6M2024-11-15: 2.6M2024-11-29: 2.6M2024-12-13: 2.5M2024-12-31: 2.5M2025-01-15: 2.7M2025-01-31: 2.5M2025-02-14: 2.5M2025-02-28: 2.5M2025-03-14: 2.4M2025-03-31: 2.2M2025-04-15: 2.8M2025-04-30: 5.5M2025-05-15: 5.9M
    the 15 May 2025 report24 earlier reportsnormal: 2.6M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  20. 10 May 2025Short interest and volume change

    had 5.5M shares sold short in the 30 Apr 2025 report, 1.6× the same report last year.

    Same report last year: 3.3M; its normal report is 2.6M.

    See the evidence
    This period
    5.5M (the 30 Apr 2025 report)
    Normal report (median of 24 earlier)
    2.6M
    Typical spread (median absolute deviation)
    145K
    How far from its usual level
    +10.6
    Same report last year
    3.3M
    History used
    2,679 days
    2024-04-30: 3.3M2024-05-15: 3.0M2024-05-31: 2.3M2024-06-14: 2.7M2024-06-28: 3.4M2024-07-15: 3.1M2024-07-31: 3.0M2024-08-15: 3.0M2024-08-30: 2.8M2024-09-13: 2.6M2024-09-30: 2.7M2024-10-15: 2.8M2024-10-31: 2.6M2024-11-15: 2.6M2024-11-29: 2.6M2024-12-13: 2.5M2024-12-31: 2.5M2025-01-15: 2.7M2025-01-31: 2.5M2025-02-14: 2.5M2025-02-28: 2.5M2025-03-14: 2.4M2025-03-31: 2.2M2025-04-15: 2.8M2025-04-30: 5.5M
    the 30 Apr 2025 report24 earlier reportsnormal: 2.6M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  21. 20 Dec 2024Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  22. 20 Dec 2024Filings record

    Director or officer change

  23. 14 Aug 2024Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  24. 14 Aug 2024Filings record

    Director or officer change

  25. 10 Aug 2024Short interest and volume change

    had 3.0M shares sold short in the 31 Jul 2024 report, 5.5× the same report last year.

    Same report last year: 538K; its normal report is 720K.

    See the evidence
    This period
    3.0M (the 31 Jul 2024 report)
    Normal report (median of 24 earlier)
    720K
    Typical spread (median absolute deviation)
    285K
    How far from its usual level
    +5.3
    Same report last year
    538K
    History used
    2,406 days
    2023-07-31: 538K2023-08-15: 442K2023-08-31: 501K2023-09-15: 601K2023-09-29: 619K2023-10-13: 618K2023-10-31: 630K2023-11-15: 604K2023-11-30: 549K2023-12-15: 429K2023-12-29: 604K2024-01-12: 662K2024-01-31: 778K2024-02-15: 1.6M2024-02-29: 1.6M2024-03-15: 1.7M2024-03-28: 2.0M2024-04-15: 2.1M2024-04-30: 3.3M2024-05-15: 3.0M2024-05-31: 2.3M2024-06-14: 2.7M2024-06-28: 3.4M2024-07-15: 3.1M2024-07-31: 3.0M
    the 31 Jul 2024 report24 earlier reportsnormal: 720K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  26. 25 Jul 2024Short interest and volume change

    had 3.1M shares sold short in the 15 Jul 2024 report, 4.1× the same report last year.

    Same report last year: 742K; its normal report is 702K.

    See the evidence
    This period
    3.1M (the 15 Jul 2024 report)
    Normal report (median of 24 earlier)
    702K
    Typical spread (median absolute deviation)
    231K
    How far from its usual level
    +6.9
    Same report last year
    742K
    History used
    2,390 days
    2023-07-14: 742K2023-07-31: 538K2023-08-15: 442K2023-08-31: 501K2023-09-15: 601K2023-09-29: 619K2023-10-13: 618K2023-10-31: 630K2023-11-15: 604K2023-11-30: 549K2023-12-15: 429K2023-12-29: 604K2024-01-12: 662K2024-01-31: 778K2024-02-15: 1.6M2024-02-29: 1.6M2024-03-15: 1.7M2024-03-28: 2.0M2024-04-15: 2.1M2024-04-30: 3.3M2024-05-15: 3.0M2024-05-31: 2.3M2024-06-14: 2.7M2024-06-28: 3.4M2024-07-15: 3.1M
    the 15 Jul 2024 report24 earlier reportsnormal: 702K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  27. 11 Jul 2024Short interest and volume change

    had 3.4M shares sold short in the 28 Jun 2024 report, 6.3× the same report last year.

    Same report last year: 536K; its normal report is 646K.

    See the evidence
    This period
    3.4M (the 28 Jun 2024 report)
    Normal report (median of 24 earlier)
    646K
    Typical spread (median absolute deviation)
    139K
    How far from its usual level
    +13.2
    Same report last year
    536K
    History used
    2,373 days
    2023-06-30: 536K2023-07-14: 742K2023-07-31: 538K2023-08-15: 442K2023-08-31: 501K2023-09-15: 601K2023-09-29: 619K2023-10-13: 618K2023-10-31: 630K2023-11-15: 604K2023-11-30: 549K2023-12-15: 429K2023-12-29: 604K2024-01-12: 662K2024-01-31: 778K2024-02-15: 1.6M2024-02-29: 1.6M2024-03-15: 1.7M2024-03-28: 2.0M2024-04-15: 2.1M2024-04-30: 3.3M2024-05-15: 3.0M2024-05-31: 2.3M2024-06-14: 2.7M2024-06-28: 3.4M
    the 28 Jun 2024 report24 earlier reportsnormal: 646K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  28. 27 Jun 2024Short interest and volume change

    had 2.7M shares sold short in the 14 Jun 2024 report, 5.6× the same report last year.

    Same report last year: 471K; its normal report is 625K.

    See the evidence
    This period
    2.7M (the 14 Jun 2024 report)
    Normal report (median of 24 earlier)
    625K
    Typical spread (median absolute deviation)
    139K
    How far from its usual level
    +9.9
    Same report last year
    471K
    History used
    2,359 days
    2023-06-15: 471K2023-06-30: 536K2023-07-14: 742K2023-07-31: 538K2023-08-15: 442K2023-08-31: 501K2023-09-15: 601K2023-09-29: 619K2023-10-13: 618K2023-10-31: 630K2023-11-15: 604K2023-11-30: 549K2023-12-15: 429K2023-12-29: 604K2024-01-12: 662K2024-01-31: 778K2024-02-15: 1.6M2024-02-29: 1.6M2024-03-15: 1.7M2024-03-28: 2.0M2024-04-15: 2.1M2024-04-30: 3.3M2024-05-15: 3.0M2024-05-31: 2.3M2024-06-14: 2.7M
    the 14 Jun 2024 report24 earlier reportsnormal: 625K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  29. 12 Jun 2024Short interest and volume change

    had 2.3M shares sold short in the 31 May 2024 report, 5.3× the same report last year.

    Same report last year: 435K; its normal report is 619K.

    See the evidence
    This period
    2.3M (the 31 May 2024 report)
    Normal report (median of 24 earlier)
    619K
    Typical spread (median absolute deviation)
    136K
    How far from its usual level
    +8.3
    Same report last year
    435K
    History used
    2,345 days
    2023-05-31: 435K2023-06-15: 471K2023-06-30: 536K2023-07-14: 742K2023-07-31: 538K2023-08-15: 442K2023-08-31: 501K2023-09-15: 601K2023-09-29: 619K2023-10-13: 618K2023-10-31: 630K2023-11-15: 604K2023-11-30: 549K2023-12-15: 429K2023-12-29: 604K2024-01-12: 662K2024-01-31: 778K2024-02-15: 1.6M2024-02-29: 1.6M2024-03-15: 1.7M2024-03-28: 2.0M2024-04-15: 2.1M2024-04-30: 3.3M2024-05-15: 3.0M2024-05-31: 2.3M
    the 31 May 2024 report24 earlier reportsnormal: 619K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  30. 25 May 2024Short interest and volume change

    had 3.0M shares sold short in the 15 May 2024 report, 8.2× the same report last year.

    Same report last year: 367K; its normal report is 611K.

    See the evidence
    This period
    3.0M (the 15 May 2024 report)
    Normal report (median of 24 earlier)
    611K
    Typical spread (median absolute deviation)
    136K
    How far from its usual level
    +12.0
    Same report last year
    367K
    History used
    2,329 days
    2023-05-15: 367K2023-05-31: 435K2023-06-15: 471K2023-06-30: 536K2023-07-14: 742K2023-07-31: 538K2023-08-15: 442K2023-08-31: 501K2023-09-15: 601K2023-09-29: 619K2023-10-13: 618K2023-10-31: 630K2023-11-15: 604K2023-11-30: 549K2023-12-15: 429K2023-12-29: 604K2024-01-12: 662K2024-01-31: 778K2024-02-15: 1.6M2024-02-29: 1.6M2024-03-15: 1.7M2024-03-28: 2.0M2024-04-15: 2.1M2024-04-30: 3.3M2024-05-15: 3.0M
    the 15 May 2024 report24 earlier reportsnormal: 611K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  31. 21 May 2024Insiders record

    Alland Leila (director) bought 11,000 shares of ABEO ($51,810) (dated 20 May 2024)

  32. 10 May 2024Short interest and volume change

    had 3.3M shares sold short in the 30 Apr 2024 report, 6.5× the same report last year.

    Same report last year: 512K; its normal report is 604K.

    See the evidence
    This period
    3.3M (the 30 Apr 2024 report)
    Normal report (median of 24 earlier)
    604K
    Typical spread (median absolute deviation)
    118K
    How far from its usual level
    +15.7
    Same report last year
    512K
    History used
    2,314 days
    2023-04-28: 512K2023-05-15: 367K2023-05-31: 435K2023-06-15: 471K2023-06-30: 536K2023-07-14: 742K2023-07-31: 538K2023-08-15: 442K2023-08-31: 501K2023-09-15: 601K2023-09-29: 619K2023-10-13: 618K2023-10-31: 630K2023-11-15: 604K2023-11-30: 549K2023-12-15: 429K2023-12-29: 604K2024-01-12: 662K2024-01-31: 778K2024-02-15: 1.6M2024-02-29: 1.6M2024-03-15: 1.7M2024-03-28: 2.0M2024-04-15: 2.1M2024-04-30: 3.3M
    the 30 Apr 2024 report24 earlier reportsnormal: 604K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  33. 30 Apr 2024several at once

    had 4 insiders buy $102K of its shares on the open market within 30 days (4 filings), while it had 3.4M shares sold short in the 28 Jun 2024 report, 6.3× the same report last year. Two unrelated kinds of activity within 133 days.

    See the evidence (11 changes)

    Short interest and volume: Short interest spike became public on 27 Mar 2024

    Abeona Therapeutics had 1.7M shares sold short in the 15 Mar 2024 report, 2.8× the same report last year.

    This period
    1.7M (the 15 Mar 2024 report)
    Normal report (median of 24 earlier)
    603K
    Typical spread (median absolute deviation)
    78K
    How far from its usual level
    +9.5
    Same report last year
    604K
    History used
    2,268 days
    2023-03-15: 604K2023-03-31: 751K2023-04-14: 601K2023-04-28: 512K2023-05-15: 367K2023-05-31: 435K2023-06-15: 471K2023-06-30: 536K2023-07-14: 742K2023-07-31: 538K2023-08-15: 442K2023-08-31: 501K2023-09-15: 601K2023-09-29: 619K2023-10-13: 618K2023-10-31: 630K2023-11-15: 604K2023-11-30: 549K2023-12-15: 429K2023-12-29: 604K2024-01-12: 662K2024-01-31: 778K2024-02-15: 1.6M2024-02-29: 1.6M2024-03-15: 1.7M
    the 15 Mar 2024 report24 earlier reportsnormal: 603K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

    Short interest and volume: Short interest spike became public on 10 Apr 2024

    Abeona Therapeutics had 2.0M shares sold short in the 28 Mar 2024 report, 2.7× the same report last year.

    This period
    2.0M (the 28 Mar 2024 report)
    Normal report (median of 24 earlier)
    603K
    Typical spread (median absolute deviation)
    96K
    How far from its usual level
    +9.8
    Same report last year
    751K
    History used
    2,281 days
    2023-03-31: 751K2023-04-14: 601K2023-04-28: 512K2023-05-15: 367K2023-05-31: 435K2023-06-15: 471K2023-06-30: 536K2023-07-14: 742K2023-07-31: 538K2023-08-15: 442K2023-08-31: 501K2023-09-15: 601K2023-09-29: 619K2023-10-13: 618K2023-10-31: 630K2023-11-15: 604K2023-11-30: 549K2023-12-15: 429K2023-12-29: 604K2024-01-12: 662K2024-01-31: 778K2024-02-15: 1.6M2024-02-29: 1.6M2024-03-15: 1.7M2024-03-28: 2.0M
    the 28 Mar 2024 report24 earlier reportsnormal: 603K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

    Insiders: Clustered insider buying became public on 30 Apr 2024

    Abeona Therapeutics had 4 insiders buy $102K of its shares on the open market within 30 days (4 filings).

    Independent buyers
    4
    Purchase filings (Form 4, code P)
    4
    Total bought
    $102K
    Window
    31 Mar 2024 to 30 Apr 2024

    Fires when at least 3 independent insiders (joint filers count once) buy on the open market in 30 days, in at least 2 filings, for $100K or more in total; amendments do not count.

    Short interest and volume: Short interest spike became public on 25 Apr 2024

    Abeona Therapeutics had 2.1M shares sold short in the 15 Apr 2024 report, 3.4× the same report last year.

    This period
    2.1M (the 15 Apr 2024 report)
    Normal report (median of 24 earlier)
    603K
    Typical spread (median absolute deviation)
    96K
    How far from its usual level
    +10.2
    Same report last year
    601K
    History used
    2,299 days
    2023-04-14: 601K2023-04-28: 512K2023-05-15: 367K2023-05-31: 435K2023-06-15: 471K2023-06-30: 536K2023-07-14: 742K2023-07-31: 538K2023-08-15: 442K2023-08-31: 501K2023-09-15: 601K2023-09-29: 619K2023-10-13: 618K2023-10-31: 630K2023-11-15: 604K2023-11-30: 549K2023-12-15: 429K2023-12-29: 604K2024-01-12: 662K2024-01-31: 778K2024-02-15: 1.6M2024-02-29: 1.6M2024-03-15: 1.7M2024-03-28: 2.0M2024-04-15: 2.1M
    the 15 Apr 2024 report24 earlier reportsnormal: 603K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

    Short interest and volume: Short interest spike became public on 10 May 2024

    Abeona Therapeutics had 3.3M shares sold short in the 30 Apr 2024 report, 6.5× the same report last year.

    This period
    3.3M (the 30 Apr 2024 report)
    Normal report (median of 24 earlier)
    604K
    Typical spread (median absolute deviation)
    118K
    How far from its usual level
    +15.7
    Same report last year
    512K
    History used
    2,314 days
    2023-04-28: 512K2023-05-15: 367K2023-05-31: 435K2023-06-15: 471K2023-06-30: 536K2023-07-14: 742K2023-07-31: 538K2023-08-15: 442K2023-08-31: 501K2023-09-15: 601K2023-09-29: 619K2023-10-13: 618K2023-10-31: 630K2023-11-15: 604K2023-11-30: 549K2023-12-15: 429K2023-12-29: 604K2024-01-12: 662K2024-01-31: 778K2024-02-15: 1.6M2024-02-29: 1.6M2024-03-15: 1.7M2024-03-28: 2.0M2024-04-15: 2.1M2024-04-30: 3.3M
    the 30 Apr 2024 report24 earlier reportsnormal: 604K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

    Short interest and volume: Short interest spike became public on 25 May 2024

    Abeona Therapeutics had 3.0M shares sold short in the 15 May 2024 report, 8.2× the same report last year.

    This period
    3.0M (the 15 May 2024 report)
    Normal report (median of 24 earlier)
    611K
    Typical spread (median absolute deviation)
    136K
    How far from its usual level
    +12.0
    Same report last year
    367K
    History used
    2,329 days
    2023-05-15: 367K2023-05-31: 435K2023-06-15: 471K2023-06-30: 536K2023-07-14: 742K2023-07-31: 538K2023-08-15: 442K2023-08-31: 501K2023-09-15: 601K2023-09-29: 619K2023-10-13: 618K2023-10-31: 630K2023-11-15: 604K2023-11-30: 549K2023-12-15: 429K2023-12-29: 604K2024-01-12: 662K2024-01-31: 778K2024-02-15: 1.6M2024-02-29: 1.6M2024-03-15: 1.7M2024-03-28: 2.0M2024-04-15: 2.1M2024-04-30: 3.3M2024-05-15: 3.0M
    the 15 May 2024 report24 earlier reportsnormal: 611K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

    Short interest and volume: Short interest spike became public on 12 Jun 2024

    Abeona Therapeutics had 2.3M shares sold short in the 31 May 2024 report, 5.3× the same report last year.

    This period
    2.3M (the 31 May 2024 report)
    Normal report (median of 24 earlier)
    619K
    Typical spread (median absolute deviation)
    136K
    How far from its usual level
    +8.3
    Same report last year
    435K
    History used
    2,345 days
    2023-05-31: 435K2023-06-15: 471K2023-06-30: 536K2023-07-14: 742K2023-07-31: 538K2023-08-15: 442K2023-08-31: 501K2023-09-15: 601K2023-09-29: 619K2023-10-13: 618K2023-10-31: 630K2023-11-15: 604K2023-11-30: 549K2023-12-15: 429K2023-12-29: 604K2024-01-12: 662K2024-01-31: 778K2024-02-15: 1.6M2024-02-29: 1.6M2024-03-15: 1.7M2024-03-28: 2.0M2024-04-15: 2.1M2024-04-30: 3.3M2024-05-15: 3.0M2024-05-31: 2.3M
    the 31 May 2024 report24 earlier reportsnormal: 619K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

    Short interest and volume: Short interest spike became public on 27 Jun 2024

    Abeona Therapeutics had 2.7M shares sold short in the 14 Jun 2024 report, 5.6× the same report last year.

    This period
    2.7M (the 14 Jun 2024 report)
    Normal report (median of 24 earlier)
    625K
    Typical spread (median absolute deviation)
    139K
    How far from its usual level
    +9.9
    Same report last year
    471K
    History used
    2,359 days
    2023-06-15: 471K2023-06-30: 536K2023-07-14: 742K2023-07-31: 538K2023-08-15: 442K2023-08-31: 501K2023-09-15: 601K2023-09-29: 619K2023-10-13: 618K2023-10-31: 630K2023-11-15: 604K2023-11-30: 549K2023-12-15: 429K2023-12-29: 604K2024-01-12: 662K2024-01-31: 778K2024-02-15: 1.6M2024-02-29: 1.6M2024-03-15: 1.7M2024-03-28: 2.0M2024-04-15: 2.1M2024-04-30: 3.3M2024-05-15: 3.0M2024-05-31: 2.3M2024-06-14: 2.7M
    the 14 Jun 2024 report24 earlier reportsnormal: 625K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

    Short interest and volume: Short interest spike became public on 11 Jul 2024

    Abeona Therapeutics had 3.4M shares sold short in the 28 Jun 2024 report, 6.3× the same report last year.

    This period
    3.4M (the 28 Jun 2024 report)
    Normal report (median of 24 earlier)
    646K
    Typical spread (median absolute deviation)
    139K
    How far from its usual level
    +13.2
    Same report last year
    536K
    History used
    2,373 days
    2023-06-30: 536K2023-07-14: 742K2023-07-31: 538K2023-08-15: 442K2023-08-31: 501K2023-09-15: 601K2023-09-29: 619K2023-10-13: 618K2023-10-31: 630K2023-11-15: 604K2023-11-30: 549K2023-12-15: 429K2023-12-29: 604K2024-01-12: 662K2024-01-31: 778K2024-02-15: 1.6M2024-02-29: 1.6M2024-03-15: 1.7M2024-03-28: 2.0M2024-04-15: 2.1M2024-04-30: 3.3M2024-05-15: 3.0M2024-05-31: 2.3M2024-06-14: 2.7M2024-06-28: 3.4M
    the 28 Jun 2024 report24 earlier reportsnormal: 646K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

    Short interest and volume: Short interest spike became public on 25 Jul 2024

    Abeona Therapeutics had 3.1M shares sold short in the 15 Jul 2024 report, 4.1× the same report last year.

    This period
    3.1M (the 15 Jul 2024 report)
    Normal report (median of 24 earlier)
    702K
    Typical spread (median absolute deviation)
    231K
    How far from its usual level
    +6.9
    Same report last year
    742K
    History used
    2,390 days
    2023-07-14: 742K2023-07-31: 538K2023-08-15: 442K2023-08-31: 501K2023-09-15: 601K2023-09-29: 619K2023-10-13: 618K2023-10-31: 630K2023-11-15: 604K2023-11-30: 549K2023-12-15: 429K2023-12-29: 604K2024-01-12: 662K2024-01-31: 778K2024-02-15: 1.6M2024-02-29: 1.6M2024-03-15: 1.7M2024-03-28: 2.0M2024-04-15: 2.1M2024-04-30: 3.3M2024-05-15: 3.0M2024-05-31: 2.3M2024-06-14: 2.7M2024-06-28: 3.4M2024-07-15: 3.1M
    the 15 Jul 2024 report24 earlier reportsnormal: 702K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

    Short interest and volume: Short interest spike became public on 10 Aug 2024

    Abeona Therapeutics had 3.0M shares sold short in the 31 Jul 2024 report, 5.5× the same report last year.

    This period
    3.0M (the 31 Jul 2024 report)
    Normal report (median of 24 earlier)
    720K
    Typical spread (median absolute deviation)
    285K
    How far from its usual level
    +5.3
    Same report last year
    538K
    History used
    2,406 days
    2023-07-31: 538K2023-08-15: 442K2023-08-31: 501K2023-09-15: 601K2023-09-29: 619K2023-10-13: 618K2023-10-31: 630K2023-11-15: 604K2023-11-30: 549K2023-12-15: 429K2023-12-29: 604K2024-01-12: 662K2024-01-31: 778K2024-02-15: 1.6M2024-02-29: 1.6M2024-03-15: 1.7M2024-03-28: 2.0M2024-04-15: 2.1M2024-04-30: 3.3M2024-05-15: 3.0M2024-05-31: 2.3M2024-06-14: 2.7M2024-06-28: 3.4M2024-07-15: 3.1M2024-07-31: 3.0M
    the 31 Jul 2024 report24 earlier reportsnormal: 720K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

    Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.

  34. 30 Apr 2024Insiders change

    had 4 insiders buy $102K of its shares on the open market within 30 days (4 filings).

    Who bought: Vazzano Joseph Walter, O'Malley Brendan M., Charles Faith L., Seshadri Vishwas.

    See the evidence (4 source records)
    Independent buyers
    4
    Purchase filings (Form 4, code P)
    4
    Total bought
    $102K
    Window
    31 Mar 2024 to 30 Apr 2024

    Fires when at least 3 independent insiders (joint filers count once) buy on the open market in 30 days, in at least 2 filings, for $100K or more in total; amendments do not count.

  35. 30 Apr 2024Insiders record

    Seshadri Vishwas (Chief Executive Officer) bought 10,000 shares of ABEO ($32,000) (dated 29 Apr 2024)

  36. 30 Apr 2024Insiders record

    Charles Faith L. (director) bought 7,550 shares of ABEO ($24,764) (dated 29 Apr 2024)

  37. 27 Apr 2024Insiders record

    O'Malley Brendan M. (SVP, General Counsel) bought 8,600 shares of ABEO ($27,864) (dated 26 Apr 2024)

  38. 27 Apr 2024Insiders record

    Vazzano Joseph Walter (Chief Financial Officer) bought 5,608 shares of ABEO ($17,609) (dated 26 Apr 2024)

  39. 25 Apr 2024Short interest and volume change

    had 2.1M shares sold short in the 15 Apr 2024 report, 3.4× the same report last year.

    Same report last year: 601K; its normal report is 603K.

    See the evidence
    This period
    2.1M (the 15 Apr 2024 report)
    Normal report (median of 24 earlier)
    603K
    Typical spread (median absolute deviation)
    96K
    How far from its usual level
    +10.2
    Same report last year
    601K
    History used
    2,299 days
    2023-04-14: 601K2023-04-28: 512K2023-05-15: 367K2023-05-31: 435K2023-06-15: 471K2023-06-30: 536K2023-07-14: 742K2023-07-31: 538K2023-08-15: 442K2023-08-31: 501K2023-09-15: 601K2023-09-29: 619K2023-10-13: 618K2023-10-31: 630K2023-11-15: 604K2023-11-30: 549K2023-12-15: 429K2023-12-29: 604K2024-01-12: 662K2024-01-31: 778K2024-02-15: 1.6M2024-02-29: 1.6M2024-03-15: 1.7M2024-03-28: 2.0M2024-04-15: 2.1M
    the 15 Apr 2024 report24 earlier reportsnormal: 603K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  40. 24 Apr 2024Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

Showing the newest 40 of 107 entries; narrow the window or the kind of data to see older ones.

Not listed: 247 routine records (quarterly and annual reports, results releases, other 8-K items, material agreements and individual insider sales), counted over all history.

Identifiers and sources

How records are matched to this company, and what each source holds for it

Cik
0000318306
Ticker
ABEO
Domain
abeonatherapeutics.com
Hq location
OH|CLEVELAND|44103 (1 unverified)
Name
Abeona, Abeona Therapeutics Inc., ACCESS PHARMACEUTICALS INC, CHEMEX PHARMACEUTICALS INC and 7 more
Uei
DYW5NUA6W5K3
  • SEC Form 13F institutional holdings414 data points30 Jun 2015 to 30 Sep 2026
  • SEC EDGAR filings (8-K items, S-1, Form D, 10-K/10-Q)192 records30 Mar 2016 to 9 Nov 2026
  • SEC XBRL company facts (revenue, capex, R&D, backlog...)1005 data points31 Dec 2009 to 5 Nov 2026
  • SEC Form 4 insider transactions119 records, 312 data points28 Sep 2016 to 16 Nov 2026
  • FINRA short interest (twice monthly)636 data points29 Dec 2017 to 30 Oct 2026
  • FINRA daily short sale volume (off-exchange)4178 data points1 Aug 2018 to 20 Nov 2026